International Journal of Nanomedicine · 2017 · 41 citations · 38 references
PharmacyPharmaceuticsPharmacologyAntimicrobial ResistanceBiomaterialsDrug DeliveryAntimicrobial BiomaterialsAntimicrobial PeptidesDrug EncapsulationLipid-based Drug Delivery SystemsLipid-based NanoparticlesNanomaterials For Drug DeliveryAntibacterial BiomaterialsAntibacterial PeptidesAntibacterial PropertiesAntimicrobial Drug DeliveryAntimicrobial Peptide ActivityNanoparticle AdsorptionNanoparticle-based AntimicrobialsNovel Antibacterial Agents
Abstract: Development of effective antibacterial agents for the treatment of infections caused by Gram-positive bacteria resistant to existing antibiotics, such as methicillin-resistant Staphylococcus aureus (MRSA), is an area of intensive research. In this work, the antibacterial efficacy of two antimicrobial peptides derived from plectasin, AP114 and AP138, used alone and in combination with monolaurin-lipid nanocapsules (ML-LNCs) was evaluated. Several interesting findings emerged from the present study. First, ML-LNCs and both plectasin derivatives showed potent activity against all 14 tested strains of S. aureus , independent of their resistance phenotype. Both peptides displayed a considerable adsorption (33%–62%) onto ML-LNCs without having an important impact on the particle properties such as size. The combinations of peptide with ML-LNC displayed synergistic effect against S. aureus , as confirmed by two methods: checkerboard and time-kill assays. This synergistic interaction enables a dose reduction and consequently decreases the risk of toxicity and has the potential of minimizing the development of resistance. Together, these results suggest that ML-LNCs loaded with a plectasin derivative may be a very promising drug delivery system for further development as a novel antibacterial agent against S. aureus , including MRSA. Keywords: nanoparticles, antimicrobial peptides, glycerol monolaurate, synergy, antibiotic resistance, MRSA, methicillin-resistant Staphylococcus aureus
38
Antimicrobial peptides of multicellular organisms
Michael Zasloff · Nature · 2002 · 8.4K citations
Andreas Peschel, Ralph W. Jack, Michaël Otto et al. · The Journal of Experimental Medicine · 2001 · 776 citations · Full text
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Per Mygind, Rikke L. Fischer, Kirk Schnorr et al. · Nature · 2005 · 656 citations
Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
Tanja Schneider, Thomas Kruse, Reinhard Wimmer et al. · Science · 2010 · 547 citations · Full text